The FDA ensures generic drugs are as safe and effective as brand-name drugs through strict manufacturing oversight, bioequivalence testing, global inspections, and continuous safety monitoring. Over 90% of U.S. prescriptions are generics-here’s how they’re kept safe.
Read More
The Hatch-Waxman Act revolutionized U.S. drug access by creating a legal pathway for generic drugs to enter the market without repeating clinical trials. It saved trillions and now governs how 90% of prescriptions are filled.
Read More
Generic inhalers, patches, and injections must meet strict bioequivalence standards to ensure they work like the brand. Learn how regulators test these complex drugs-and why so many fail.
Read More
